Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

Platelet-rich plasma may improve wound healing by stimulating cell growth and blood vessel formation.

Platelet-rich plasma (PRP) shows no significant benefit for bone and soft-tissue injuries or wound healing, and its effectiveness may improve with customization.

Pulsed electric field treatment may help the immune system fight liver tumors.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

PRP treatment can safely improve short-term vision in acute NAION patients.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Human placental extract may help hair growth by affecting certain cell signals and could be more effective with minoxidil.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Platelet-rich plasma with a new carrier significantly increases hair thickness without serious side effects.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.